Clinical Trials on Skin Microbiome in Hong Kong

Total 900 results

GlaxoSmithKline

Completed

Pilot Study of Patient's Adherence to TYKERB™/TYVERB™ + Capecitabine in Metastatic Breast Cancer

Cancer

Korea, Republic of, Hong Kong, Pakistan, Singapore
Novartis Pharmaceuticals

Terminated

Lapatinib +Capecitabine Treatment for Advanced Metastatic Breast Cancer in Women From China

Neoplasms, Breast

Hong Kong, China
Nordic Bioscience A/S
Novartis

Completed

Efficacy and Safety of Oral Salmon Calcitonin in Patients With Knee Osteoarthritis

Osteoarthritis

Denmark, Estonia, Hong Kong, Poland, Romania, Czechia
GlaxoSmithKline

Terminated

A Clinical Research Study For The Suppression And Treatment Of Genital Herpes Infection In HIV-Infected Persons

Herpes Genitalis

United States, Australia, Hong Kong
Zhujiang Hospital
Nanfang Hospital of Southern Medical University; First Affiliated Hospital... and other collaborators

Recruiting

A Multicenter Cohort Study on Maternal and Infant Microecology and New Targets for Pre-eclampsia Screening in China (CALM2001)

Preeclampsia | Microbiome

China
DePuy International

Terminated

A Multi-centre Study to Assess the Long-term Performance of the Summit™ Hip in Primary Total Hip Replacement

Osteoarthritis | Rheumatoid Arthritis | Avascular Necrosis | Post-traumatic Arthritis | Congenital Hip Dysplasia | Slipped Capital Femoral Epiphysis | Collagen Disorders | Traumatic Femoral Fractures | Nonunion of Femoral Fractures

China, Hong Kong, Italy, Korea, Republic of, New Zealand
Athenex, Inc.

Completed

A Study of Oraxol in Subjects With Cutaneous Angiosarcoma

Angiosarcoma of Skin

United States, United Kingdom, Taiwan, Hong Kong
Pfizer

Terminated

Study Evaluating Bosutinib-Letrozole Combination Versus Letrozole Alone In Post Menopausal Women With Breast Cancer

Breast Cancer

United States, Belgium, Hungary, China, Hong Kong, Poland, Singapore
Mundipharma Pte Ltd.
Mundipharma Korea Ltd; Mundipharma (Hong Kong) Ltd; Mundipharma Distribution...

Completed

Evaluation Of Efficacy And Safety Of Norspan In Moderate To Severe Pain Due To Osteoarthritis, Rheumatoid Arthritis, Joint/Muscle Pain

Osteoarthritis | Rheumatoid Arthritis | Lower Back Pain | Joint Pain | Muscle Pain

Hong Kong, Korea, Republic of, Philippines
Sun Pharmaceutical Industries Limited
Moebius Medical Ltd.; Nordic Bioscience Clinical Development (NBCD)

Completed

Efficacy and Safety of MM-II for Treatment of Knee Pain in Subjects With Symptomatic Knee Osteoarthritis

Osteoarthritis of Knee

United States, Denmark, Hong Kong
Novartis Pharmaceuticals

Completed

Efficacy Study of MCS110 Given With Carboplatin and Gemcitabine in Advanced Triple Negative Breast Cancer (TNBC) (TNBC)

Advanced Triple Negative Breast Cancer (TNBC) With High TAMs

France, Italy, Austria, Taiwan, United States, Spain, Australia, Korea, Republic of, Belgium, Germany, Hong Kong, Turkey
Levicept
Nordic Bioscience Clinical Development (NBCD)

Active, not recruiting

Clinical Trial to Evaluate the Efficacy and Safety of LEVI-04 in Patients With Osteoarthritis of the Knee

Pain | Arthritis | Joint Diseases | Musculoskeletal Diseases | Rheumatic Diseases | Knee Osteoarthritis | Osteo Arthritis Knee

Poland, Czechia, Denmark, Hong Kong, Moldova, Republic of
Pfizer

Terminated

Study Of Bosutinib With Capecitabine In Solid Tumors And Locally Advanced Or Metastatic Breast Cancer

Advanced Breast Cancer (Parts 1 and 2) | Advanced Pancreatic Cancer (Part 1) | Advanced Colorectal Cancer (Part 1) | Advanced Cholangiocarcinoma (Part 1) | Advanced Glioblastoma Multiforme (Part 1)

United States, Spain, Hong Kong, Belgium, Australia, France
Uppsala University
Baylor College of Medicine; Sahlgrenska University Hospital, Sweden; University... and other collaborators

Recruiting

Delayed Sentinel Lymph Node Biopsy in Ductal Cancer in Situ (SENTINOT_2)

Breast Cancer | Breast Neoplasms | Sentinel Lymph Node | DCIS

United States, Sweden, Hong Kong
ASLAN Pharmaceuticals

Completed

Study of ASLAN001 in Combination With Capecitabine in MBC That Has Failed on Prior Trastuzumab

Metastatic Breast Cancer

Australia, Hong Kong, Korea, Republic of, New Zealand, Philippines, Singapore, Taiwan
Zai Lab (Shanghai) Co., Ltd.

Terminated

A Study of Niraparib Combined With MGD013 in Patients With Advanced or Metastatic Solid Tumor Who Failed Prior Treatment

Gastric Cancer | Triple Negative Breast Cancer | Endometrial Carcinoma | Biliary Tract Carcinoma

China
GlaxoSmithKline

Completed

Study of Biomarker Profiles in Asia Pacific erb2+/HER2 Breast Cancer Patients Treated With Lapatinib (BioPATH)

Neoplasms, Metastasis

Korea, Republic of, Hong Kong, Philippines, Singapore
Puma Biotechnology, Inc.

Completed

Temsirolimus Plus Neratinib for Patients With Metastatic HER2-Amplified or Triple Negative Breast Cancer

Breast Cancer

Spain, United Kingdom, France, United States, Denmark, Hong Kong
Washington University School of Medicine
National Public Health Institute of Liberia

Not yet recruiting

Safety and Efficacy of Novel Combination Regimens for Treatment of Onchocerciasis

Onchocerciasis | Onchocerciasis, Ocular | Tropical Disease | Onchocercal Subcutaneous Nodule | Onchocerca Infection

Liberia
Novartis Pharmaceuticals

Completed

Study to Investigate the Objective Response Rate of Dabrafenib in Combination With Trametinib in Subjects With BRAF V600 Mutation-Positive Melanoma

Melanoma | Cancer

Taiwan, Thailand, China, Hong Kong, Korea, Republic of
EMD Serono Research & Development Institute, Inc.
Nordic Bioscience A/S

Completed

A Study to Investigate the Safety and Effectiveness of Different Doses of Sprifermin in Participants With Osteoarthritis of the Knee (FORWARD)

Osteoarthritis, Knee

Estonia, Romania, Hong Kong, Czechia, Denmark, Poland, Argentina, United States
Novartis Pharmaceuticals

Active, not recruiting

Study of Safety and Efficacy of DKY709 Alone or in Combination With PDR001 in Patients With Advanced Solid Tumors.

Melanoma | Carcinoma, Non-Small-Cell Lung | Nasopharyngeal Carcinoma | Triple Negative Breast Cancer | Microsatellite Stable Colorectal Cancer

United States, Taiwan, Spain, Germany, Japan, Hong Kong
Boehringer Ingelheim

Completed

LUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment Failures

Breast Neoplasms

Hong Kong, Taiwan, United Kingdom, Russian Federation, India, Poland
Novartis Pharmaceuticals

Completed

A Phase Ib Dose De-escalation Study With BYL719 in Premenopausal Patients With Locally Advanced or Metastatic Breast Cancer (B-YOND)

Pre-menopausal Breast Cancer | PI3K Pathway Inhibition

Taiwan, Hong Kong, Thailand, Korea, Republic of
Novartis Pharmaceuticals

Completed

Phase Ib Trial of LEE011 With Everolimus (RAD001) and Exemestane in the Treatment of Hormone Receptor Positive HER2 Negative Advanced Breast Cancer

Breast Cancer

United States, Spain, Belgium, Hong Kong, France
Kyoto Breast Cancer Research Network
Pfizer

Completed

Neoadjuvant Hormonal Therapy Plus Palbociclib in Operable, Hormone Sensitive and HER2-Negative Primary Breast Cancer

Hormone Receptor Positive Malignant Neoplasm of Breast | Breast Cancer Female

Taiwan, Japan, Korea, Republic of, Australia, Hong Kong
Stiefel, a GSK Company
GlaxoSmithKline

Completed

Sexual Function in Men Receiving Dutasteride for Androgenetic Alopecia

Alopecia

Korea, Republic of, Taiwan, Singapore, Hong Kong, Chile
Dong-A University

Completed

Efficacy of AFL-assisted PDT With Short Incubation Time in Actinic Keratosis

Actinic Keratosis

Korea, Republic of
Northwestern University

Completed

Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index

Psoriasis | Atopic Dermatitis

Chile, United States, Netherlands, Canada, Hong Kong, Italy
Tokyo University

Unknown

Biliary Drainage in Patients With Duodenal Metal Stent

Jaundice

Korea, Republic of, India, Japan, Thailand, Taiwan, China, Hong Kong, Malaysia, Singapore
Boehringer Ingelheim

Completed

Afatinib (BIBW2992) in HER2 (Human Epidermal Growth Factor Receptor 2)-Overexpressing Inflammatory Breast Cancer

Breast Neoplasms

United States, Australia, Hong Kong, Korea, Republic of, Thailand, Tunisia, United Kingdom
Novartis Pharmaceuticals

Completed

A Phase Ib Dose Escalation Study of the Combination of LEE011 With Letrozole and Dose Expansion of LEE011 With Hormonal Therapy for the Treatment of Pre-(With Goserelin) and Postmenopausal Women With Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer

Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer

Japan, Hong Kong, Singapore
Bone Therapeutics S.A
Nordic Bioscience A/S

Completed

Phase III Study on the Safety and Efficacy of a Single Intra-articular Administration of JTA-004 in Symptomatic Knee Osteoarthritis (JTA-KOA2)

Symptomatic Osteoarthritis of the Knee

Denmark, Belgium, United Kingdom, Czechia, Hong Kong, Moldova, Republic of, Poland
Pfizer

Completed

Study Evaluating SKI-606 (Bosutinib) In Subjects With Breast Cancer

Breast Neoplasms | Neoplasm Metastasis

United States, Ukraine, Russian Federation, Hong Kong, France, Australia, Poland, Malta
Novartis Pharmaceuticals

Terminated

Study of Safety and Efficacy of Novel Immunotherapy Combinations in Patients With Triple Negative Breast Cancer (TNBC).

Triple Negative Breast Cancer (TNBC)

Netherlands, Spain, Hong Kong, Singapore, Italy, Australia, Israel, Japan, United States
Omeros Corporation

Unknown

Safety Study of IgAN, LN, MN, & C3 Glomerulopathy Including Dense Deposit Disease Treated With OMS721

Lupus Nephritis | IgAN | C3 Glomerulopathy | MN

United States, Hong Kong
Dong-A Pharmaceutical Co., Ltd.

Unknown

Study of SI000413 in Knee Osteoarthritis Patients

Osteoarthritis, Knee

Korea, Republic of
Amgen

Completed

Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis

Systemic Lupus Erythematosus | Nephritis

United States, Hong Kong, France, Malaysia, Mexico
Spectrum Pharmaceuticals, Inc

Terminated

A Study of Poziotinib in Patients With Epidermal Growth Factor Receptor (EGFR) or Human Epidermal Growth Factor Receptor 2 (HER2) Activating Mutations in Advanced Malignancies

Breast Cancer | Colorectal Cancer | Solid Tumor | Glioblastome Multiforme

United States
Pfizer

Terminated

Study of Etanercept in Subjects With Rheumatoid Arthritis Who Have Had an Inadequate Response to Adalimumab or Infliximab Plus Methotrexate (SERUM)

Rheumatoid Arthritis

Spain, Australia, Belgium, France, Hong Kong, Israel, Russian Federation
Puma Biotechnology, Inc.

Completed

Study Evaluating The Combination Of Neratinib And Capecitabine In Solid Tumors And Breast Cancer

Breast Cancer

United States, Spain, China, Hungary, Singapore, Australia, Russian Federation, Hong Kong, Brazil, Croatia, Korea, Republic of
Novartis Pharmaceuticals

Completed

Phase I/Ib Study of NIS793 in Combination With PDR001 in Patients With Advanced Malignancies.

Breast Cancer | Colorectal Cancer | Pancreatic Cancer | Lung Cancer | Renal Cancer | Hepatocellular Cancer

Taiwan, Germany, Italy, Austria, Switzerland, Hong Kong, Japan, Canada, United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating The Safety And Tolerability Of ILV-094 In Subjects With Psoriasis

Psoriasis

United States, Hong Kong, Canada, South Africa
Novartis Pharmaceuticals

Terminated

Phase Ib Study of TNO155 in Combination With Spartalizumab or Ribociclib in Selected Malignancies

Colorectal Cancer | Gastrointestinal Stromal Tumors | Non-small Cell Lung Carcinoma | Head and Neck Squamous Cell Carcinoma | Esophageal SCC

United States, Germany, Spain, Singapore, Australia, Hong Kong, Belgium, Japan, China
Southern California Institute for Research and...
Regenesis Biomedical, Inc.

Unknown

Provant Therapy of Venous Stasis Ulcer Trial

Venous Stasis Ulcers

United States
Rutgers, The State University of New Jersey

Active, not recruiting

CIPHER Study: Pilot Study to Study the Role of ctDNA in Triple Negative and HER2 Positive Early Stage

Breast Cancer, Early-Onset

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Comparing Etanercept With Usual DMARD Therapy in Subjects With Rheumatoid Arthritis in the Asia Pacific Region

Rheumatoid Arthritis

Hong Kong, Philippines, Taiwan, Thailand, India, Korea, Republic of, Malaysia, Singapore
VA Long Beach Healthcare System
Southern California Institute for Research and Education

Unknown

A Controlled Comparison of Pulsed Radiofrequency Vs Physical Therapy on Treating Chronic Knee Osteoarthritis

Knee Osteoarthritis

United States
ORIC Pharmaceuticals

Recruiting

Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration

Solid Tumors

Korea, Republic of, United States, Australia, Taiwan, Poland, Canada, Hong Kong, United Kingdom
H. Lundbeck A/S

Terminated

A Study to Evaluate Lu AG06466 in Participants With Fibromyalgia

Fibromyalgia

United States

Clinical Trials on Skin Microbiome in Hong Kong

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Equatorial Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations